These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 38104098)

  • 1. Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.
    Gramegna A; Misuraca S; Lombardi A; Premuda C; Barone I; Ori M; Amati F; Retucci M; Nazzari E; Alicandro G; Ferrarese M; Codecasa L; Bandera A; Aliberti S; Daccò V; Blasi F
    Respir Res; 2023 Dec; 24(1):316. PubMed ID: 38104098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.
    Martiniano SL; Esther CR; Haworth CS; Kasperbauer SH; Zemanick ET; Caverly LJ
    Pediatr Pulmonol; 2020 Feb; 55(2):521-525. PubMed ID: 31821718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.
    Qvist T; Pressler T; Høiby N; Katzenstein TL
    Respir Res; 2014 Apr; 15(1):41. PubMed ID: 24725650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis.
    Eikani MS; Nugent M; Poursina A; Simpson P; Levy H
    BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis.
    Cavalli Z; Reynaud Q; Bricca R; Nove-Josserand R; Durupt S; Reix P; Perceval M; de Montclos MP; Lina G; Durieu I
    J Cyst Fibros; 2017 Sep; 16(5):579-584. PubMed ID: 28202251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis.
    Lu M; Saddi V; Britton PN; Selvadurai H; Robinson PD; Pandit C; Marais BJ; Fitzgerald DA
    Paediatr Respir Rev; 2019 Feb; 29():42-52. PubMed ID: 30473423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Thorac Surg Clin; 2019 Feb; 29(1):95-108. PubMed ID: 30454926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2022 Dec; 43(4):697-716. PubMed ID: 36344075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis-Related Nontuberculous Mycobacterial Pulmonary Disease.
    Baird T; Bell S
    Clin Chest Med; 2023 Dec; 44(4):847-860. PubMed ID: 37890921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontuberculous mycobacteria in patients with cystic fibrosis.
    Leung JM; Olivier KN
    Semin Respir Crit Care Med; 2013 Feb; 34(1):124-34. PubMed ID: 23460012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency and related factors of non-tuberculosis mycobacteria infections among patients with cystic fibrosis.
    Ademhan Tural D; Emiralioglu N; Ozsezen B; Saribas Z; Ozcan N; Alp A; Sunman B; Hizal M; Eryilmaz Polat S; Yalcin E; Dogru D; Ozcelik U; Kiper N
    Pediatr Int; 2021 Nov; 63(11):1369-1375. PubMed ID: 33682254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.
    Floto RA; Olivier KN; Saiman L; Daley CL; Herrmann JL; Nick JA; Noone PG; Bilton D; Corris P; Gibson RL; Hempstead SE; Koetz K; Sabadosa KA; Sermet-Gaudelus I; Smyth AR; van Ingen J; Wallace RJ; Winthrop KL; Marshall BC; Haworth CS;
    Thorax; 2016 Jan; 71 Suppl 1(Suppl 1):i1-22. PubMed ID: 26666259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.
    Burke A; Smith D; Coulter C; Bell SC; Thomson R; Roberts JA
    Clin Pharmacokinet; 2021 Sep; 60(9):1081-1102. PubMed ID: 33982266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers.
    Low D; Wilson DA; Flume PA
    J Cyst Fibros; 2020 Jul; 19(4):569-574. PubMed ID: 32178969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontuberculous mycobacterial infections in cystic fibrosis.
    Martiniano SL; Nick JA
    Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators.
    Burke A; Thomson RM; Wainwright CE; Bell SC
    Semin Respir Crit Care Med; 2023 Apr; 44(2):287-296. PubMed ID: 36649736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.
    Adjemian J; Olivier KN; Prevots DR
    Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF).
    Viviani L; Harrison MJ; Zolin A; Haworth CS; Floto RA
    J Cyst Fibros; 2016 Sep; 15(5):619-23. PubMed ID: 27050794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing nontuberculous mycobacteria infection in cystic fibrosis.
    Bar-On O; Mussaffi H; Mei-Zahav M; Prais D; Steuer G; Stafler P; Hananya S; Blau H
    J Cyst Fibros; 2015 Jan; 14(1):53-62. PubMed ID: 24917112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontuberculous Mycobacteria in Cystic Fibrosis.
    Richards CJ; Olivier KN
    Semin Respir Crit Care Med; 2019 Dec; 40(6):737-750. PubMed ID: 31659731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.